3-bromo-5-methoxy phenyl benzoate | 260558-16-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 缩酚酸和缩酚酸环醚类
• 英文名称: 3-bromo-5-methoxy phenyl benzoate
• 英文别名: 4-benzoyloxy-2-bromo-1-methoxy-benzene；2-Brom-hydrochinon-1-methylaether-4-benzoat；4-Benzoyloxy-2-brom-1-methoxy-benzol；4-benzoyloxy-2-bromoanisole；(3-Bromo-4-methoxyphenyl) benzoate
• CAS: 260558-16-5
• 化学式: C₁₄H₁₁BrO₃
• 分子量: 307.144
• InChiKey: DCTQSLXBOFQVTM-UHFFFAOYSA-N

物化性质

• 沸点：
  394.7±32.0 °C(Predicted)
• 密度：
  1.441±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-bromo-5-methoxy phenyl benzoate 在 sodium hydroxide 作用下， 生成 3-溴-4-甲氧基苯酚
  参考文献：
  名称：

  十三。喹啉单甲醚的溴化

  摘要：

  DOI：

  10.1039/jr9270000074
• 作为产物：
  描述：

  (4-甲氧基苯基)苯甲酸酯 在 溴 、 铁粉 、 溶剂黄146 作用下， 生成 3-bromo-5-methoxy phenyl benzoate
  参考文献：
  名称：

  十三。喹啉单甲醚的溴化

  摘要：

  DOI：

  10.1039/jr9270000074

文献信息

• Palladium-catalyzed non-directed CH benzoxylation of simple arenes with iodobenzene dibenzoates
  作者：Li Li、Ying Wang、Tingting Yang、Qian Zhang、Dong Li

  DOI：10.1016/j.tetlet.2016.11.055

  日期：2016.12

  as both benzoxylate source and oxidant has been developed. The catalytic system was greatly promoted by a pyridine ligand. Good functional groups tolerance was showed in both hypervalent iodine reagents and arene substrates, which can be used for synthesis of aryl benzoates through simple aromatic compounds.

  已开发了以碘代苯二苯甲酸酯作为苯氧基化物源和氧化剂的钯催化的简单芳烃的非定向C H苯氧基化反应。吡啶配体极大地促进了催化体系。高价碘试剂和芳烃底物均显示出良好的官能团耐受性，可用于通过简单的芳族化合物合成芳基苯甲酸酯。
• Formation of benzo[ghi]fluoranthenes by palladium catalyzed intramolecular coupling
  作者：Le Wang、Philip B. Shevlin

  DOI：10.1016/s0040-4039(99)01940-1

  日期：2000.1

  A novel synthesis of benzo[ghi]fluoranthenes by palladium mediated coupling is reported. The high yields, mild reaction conditions and functional group tolerance are an advantage of this method.

  报道了通过钯介导的偶联新合成苯并[ ghi ]氟蒽的方法。该方法的优点是高收率，温和的反应条件和官能团耐受性。
• Novel 1,2,3,4-Tetrahydroquinoxaline Derivative Having Glucocorticoid Receptor Binding Activity
  申请人：Matsuda Mamoru

  公开号：US20090111807A1

  公开（公告）日：2009-04-30

  An object of the present invention is to synthesize a novel 1,2,3,4-tetrahydroquinoxaline derivative represented by formula (1) and to find a pharmacological action of the derivative. In the formula, the R 1 represents a halogen, an alkyl, cycloalkyl, aryl or heterocyclic group, or the like; p represents 0 to 5; R 2 represents a halogen, an alkyl, hydroxyl or alkoxy group, or the like; q represents 0 to 2; R 3 represents hydrogen, an alkyl, alkenyl, alkylcarbonyl or arylcarbonyl group, or the like; R 4 and R 5 independently represent hydrogen, a halogen, an alkyl, alkenyl, alkynyl, cycloalkyl, aryl or heterocyclic group, or the like; R 6 represents hydrogen, an alkyl, alkenyl, alkynyl, cycloalkyl, aryl or heterocyclic group, or the like; A represents an alkylene; R 7 represents OR 8 , NR 8 R 9 , SR 8 , S(O)R 8 , S(O) 2 R 8 ; and X represents O or S.

  本发明的目的是合成一种新的1,2,3,4-四氢喹喔啉衍生物，其化学式表示为（1），并找到该衍生物的药理作用。其中，R1代表卤素、烷基、环烷基、芳基或杂环基等；p表示0至5；R2代表卤素、烷基、羟基或烷氧基等；q表示0至2；R3代表氢、烷基、烯基、烷基羰基或芳基羰基等；R4和R5独立地表示氢、卤素、烷基、烯基、炔基、环烷基、芳基或杂环基等；R6代表氢、烷基、烯基、炔基、环烷基、芳基或杂环基等；A代表烷基；R7代表OR8、NR8R9、SR8、S（O）R8、S（O）2R8；X代表O或S。
• 1,2,3,4-TETRAHYDROQUINOXALINE COMPOUNDS HAVING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY
  申请人：SANTEN PHARMACEUTICAL CO., LTD.

  公开号：US20130303537A1

  公开（公告）日：2013-11-14

  A 1,2,3,4-tetrahydroquinoxaline compound represented by the following formula: In the formula (1), R 1 represents substituents such as a halogen, an alkyl, a cycloalkyl, an aryl or a heterocyclic group; p represents 0 to 5; R 2 represents substituents such as a halogen, an alkyl, a hydroxyl or an alkoxy group; q represents 0 to 2; R 3 represents substituents such as hydrogen, an alkyl, an alkenyl, an alkylcarbonyl or an arylcarbonyl group; R 4 and R 5 independently represent substituents such as hydrogen, a halogen, an alkyl, an alkenyl, an alkynyl, a cycloalkyl, an aryl or a heterocyclic group; R 6 represents substituents such as hydrogen, an alkyl, an alkenyl, an alkynyl, a cycloalkyl, an aryl or a heterocyclic group; A represents an alkylene; R 7 represents OR 8 , NR 8 R 9 , SR 8 , S(O)R 8 , S(O) 2 R 8 ; R 8 and R 9 independently represent substituents such as hydrogen, an alkyl or an alkenyl; and X represents O or S.

  以下是由下式表示的1,2,3,4-四氢喹喔啉化合物：在式（1）中，R1表示卤素，烷基，环烷基，芳基或杂环基等取代基；p表示0至5；R2表示卤素，烷基，羟基或烷氧基等取代基；q表示0至2；R3表示氢，烷基，烯基，烷基羰基或芳基羰基等取代基；R4和R5独立地表示氢，卤素，烷基，烯基，炔基，环烷基，芳基或杂环基等取代基；R6表示氢，烷基，烯基，炔基，环烷基，芳基或杂环基等取代基；A表示烷基；R7表示OR8，NR8R9，SR8，S（O）R8，S（O）2R8；R8和R9独立地表示氢，烷基或烯基等取代基；X表示O或S。
• NOVEL 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE HAVING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY
  申请人：Santen Pharmaceutical Co., Ltd

  公开号：EP1995242B1

  公开（公告）日：2012-11-07